Coinfection  >>  Pegasys (pegylated interferon α -2a)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pegasys (pegylated interferon α -2a) / Roche
PERFECT, NCT02762383: Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial

Terminated
3
19
Europe
Peginterferon Alfa-2, Pegasys
Hoffmann-La Roche
HIV/HCV Coinfection
06/09
06/09
HB01EMVIPEG, NCT00391638: Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients

Completed
2/3
56
Europe
TRUVADA (EMTRICITABINE + TENOFOVIR DF), PEGASYS 180μg (Interféron pégylé alpha -2a)
French National Agency for Research on AIDS and Viral Hepatitis, Gilead Sciences, Roche Pharma AG
Hepatitis B, HIV Infections
05/11
10/12

Download Options